Larvol Delta - ASLAN-Pharmaceuticals-Enrolls-First-Patient-in-ProofofConcept-Study-for-ASLAN004-Targeting-Atopic-Dermatitis

ASLAN004 - ASLAN

http://www.globenewswire.com/news-release/2019/10/22/1932955/0/en/ASLAN-Pharmaceuticals-Enrolls-First-Patient-in-Proof-of-Concept-Study-for-ASLAN004-Targeting-Atopic-Dermatitis.html

Oct 21, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next